Havn Life Collapses

Math Over Myth: Psychedelic Stock HAVN Life Collapses

The psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow
Math over Myth MindMed

Math Over Myth: Spotlight on MindMed

In the latest installment of Math Over Myth we navigate psychedelic stock MindMed’s reverse split with Fibonacci numbers
Math over Myth ATAI Compass

Math Over Myth: Spotlight on Psychedelic Stocks ATAI & COMPASS

If you want to invest in psychedelic stocks, ignore the hype and look at the technicals. We take a deep dive on atai Life Sciences & COMPASS Pathways
ARK Invest psychedelic

Psychedelic Stocks: ARK Invest and the Reverse Midas Touch

, ,
Cathie Wood is buying up stocks from the most dubious actors in the psychedelic sector. Given ARK Invest’s subpar performance, is that a good thing?
Psychedelic Stocks

Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine Collapses

The psychedelic renaissance hits a rough patch as major companies look to tighten their belts or face total collapse. What’s happening with Psychedelic Stocks?
MindMed 18-MC Ibogaine Opioid Addiction

MindMed Shelves 18-MC for Opioid Use Disorder and Further Cuts Pipeline

MindMed drops its proprietary ibogaine for opioid addiction research amidst an ongoing shakeup. What is going on with this psychedelics company?
Cybin Entheon DMT Clinical TrialSutterstock

The Real Reason Cybin Bought Entheon’s DMT Clinical Trial

, ,
In a rare move Cybin aquires a phase 1 DMT clinical trial from Entheon Biomedical. CEO Doug Drysdale explains why in a Reddit AMA
Psychedelic Stocks Compass Small Pharma Mydecine Awakn

A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial

Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research

Psychedelic Business Spotlight – July 1

, ,
This week in psychedelic stock news: MindMed downplays delisiting fears; Red Light Holland teams with Wiz Khalifa; Field Trip shareholders approve company split; and more!
Psychedelic Business Spotlight – June 24

This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More!

, ,
This week in psychedelic stock news, there are big patent developments for Compass, MindMed and Numinus.